Obinutuzumab: a new class of anti-CD20 monoclonal antibody.

scientific article published on September 2014

Obinutuzumab: a new class of anti-CD20 monoclonal antibody. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/CCO.0000000000000107
P698PubMed publication ID25014645

P50authorGuillaume CartronQ38803376
Anne-Laure GagezQ51749890
P2093author name stringGuillaume Cartron
Anne-Laure Gagez
P2860cites workLack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicityQ30835165
P433issue5
P921main subjectmonoclonal antibodyQ422248
P304page(s)484-491
P577publication date2014-09-01
P1433published inCurrent Opinion in OncologyQ1909046
P1476titleObinutuzumab: a new class of anti-CD20 monoclonal antibody
P478volume26

Reverse relations

cites work (P2860)
Q50063710Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region
Q92718871CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis
Q38881164Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemia
Q92084382Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists
Q38329651How to successfully patent therapeutic antibodies
Q28069362Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Q28385366Mechanisms of action of therapeutic antibodies for cancer
Q38759420Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
Q37741570Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
Q33780903Pharmacokinetics of obinutuzumab in Chinese patients with B-cell lymphomas
Q40088787Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein.
Q64044243Recent advances in the management of systemic lupus erythematosus
Q35040896The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis
Q39018189The safety profile of monoclonal antibodies for chronic lymphocytic leukemia

Search more.